+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Proteinuria"

Lupus Nephritis Market Report 2025 - Product Thumbnail Image

Lupus Nephritis Market Report 2025

  • Report
  • May 2025
  • 175 Pages
  • Global
From
Diabetic Kidney Diseases - Global Strategic Business Report - Product Thumbnail Image

Diabetic Kidney Diseases - Global Strategic Business Report

  • Report
  • June 2025
  • 372 Pages
  • Global
From
From
Nephrotic Syndrome Global Market Report 2025 - Product Thumbnail Image

Nephrotic Syndrome Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Rare Kidney Diseases Market Report and Forecast 2025-2034 - Product Thumbnail Image

Rare Kidney Diseases Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
From
From
From
Chronic Renal Disease. Edition No. 2 - Product Thumbnail Image

Chronic Renal Disease. Edition No. 2

  • Book
  • November 2019
  • 16 Results (Page 1 of 1)
Loading Indicator

Proteinuria is a condition in which an abnormal amount of protein is present in the urine. It is a common symptom of kidney disease and can be caused by a variety of conditions, including diabetes, hypertension, and lupus. Proteinuria is often monitored by urologists and nephrologists, who specialize in the diagnosis and treatment of kidney diseases. Treatment for proteinuria typically involves lifestyle changes, such as reducing salt intake and increasing physical activity, as well as medications to reduce protein levels in the urine. In some cases, surgery may be necessary to repair damaged kidneys. The proteinuria market is a growing segment of the urology and nephrology industry, with a range of products and services available to diagnose and treat the condition. Companies in the market include Abbott Laboratories, AstraZeneca, B. Braun Melsungen AG, Baxter International, Fresenius Medical Care, and Merck & Co. Show Less Read more